Wei, Wen – Trademark Portfolio
Entity Type: 01
Wei, Wen holds 70 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 34 (Smokers Articles) — 38 filings in this category. The portfolio also extends into Class 8 (Hand Tools) across 13 Nice Classification classes. Currently, 10 trademarks are registered and 1 is pending. Notable registered marks include APEX, ENVY, MAKO, FORTE, and NEXUS. The owner is based in Baldwin Park, CA.
345 Cloverleaf Drive, Suite C
Baldwin Park, CA 90010
Showing of trademarks Trademarks
Trademark Classifications
Wei, Wen's trademark portfolio spans 13 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Wei, Wen have?
Wei, Wen has 70 U.S. trademarks filed with the USPTO. Of these, 10 registered, 1 pending, 13 abandoned, 46 cancelled.
What trademark classes does Wei, Wen file in?
Wei, Wen files trademarks across 13 Nice Classification classes. The most active classes are Class 34 (Smokers Articles), Class 8 (Hand Tools), Class 43 (Hotels & Restaurants), Class 20 (Furniture), Class 30 (Staple Foods). Class 34 covers tobacco; smokers articles; matches.
What are Wei, Wen's most well-known trademarks?
Wei, Wen's registered trademark portfolio includes well-known marks such as APEX, ENVY, MAKO, FORTE, and NEXUS. These are among 10 currently registered trademarks in the portfolio.
What is Wei, Wen's trademark registration success rate?
Wei, Wen has a 14% trademark registration rate, with 10 out of 69 resolved applications resulting in successful registration. Currently, 1 application is pending review.